Potential biomarkers and drug evaluation system for Alzheimer’s disease
- In: Poster Presentation
- At: Stockholm (Sweden) (2017)
- Type: Poster
- Poster code: P-A-112-Monday
- By: ZHANG, Xiang (Institute of Materia Medica, Chinese Academy of Medical Sciences, Department of Pharmacology, Beijing, China)
- Co-author(s): Xiang Zhang: Department of Pharmacology, Institute of Materia Medica, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China
Wenwen Yu: Department of Pharmacology, Institute of Materia Medica, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China
Yingni Sun: Department of Pharmacology, Institute of Materia Medica, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China
Xiaoliang Wang: Department of Pharmacology, Institute of Materia Medica, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China - Abstract:
Backgrounds
Alzheimer’s disease (AD) is a common neurodegenerative disease among elderly people. As the pathogenesis is still unclear, the diagnosis of AD at early stage and evaluation of therapeutic effects are difficult. Recently we have demonstrated some specific expressed serum proteins in AD patients.Aims
To verify the proteins changing in.. The access to the whole abstract and if available the presentation file is available to FIP members and to congress participants of that specific congress.
Please login
Last update 28 September 2023